Formulating elafibranor and obeticholic acid with phospholipids decreases drug-induced association…
Chronic hepatic diseases often compromise liver function and are directly responsible for up to two million yearly deaths world-wide. There are yet no treatment options to solve this global medical need.
Experimental drugs elafibranor…